Clinical Trial Update: Mesenchymal Stem Cells: Alterations in Genome [NA]

View source ↗

Summary

This clinical trial update reports on mesenchymal stem cells and potential genome alterations observed in patients undergoing coronary bypass surgery; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Nantes University Hospital | Conditions: Pened Chest Surgery for Programmes Coronary Bypass | NA | Status: COMPLETED